Advertisement

Underlying Principles in Ejaculatory and Orgasmic Function and Dysfunction in the Male

  • Jason M. Scovell
  • Michael L. EisenbergEmail author
Chapter

Abstract

Since sexual function relies on a myriad of complex interactions between neuroanatomical, biochemical, and psychosocial factors, understanding the mechanisms driving various sexual dysfunctions has been challenging. Our understanding of numerous mechanisms involved in male sexual function has been enhanced over the past several decades utilizing a variety of techniques ranging from animal models to human studies. Although studies of these conditions remain limited, the application of new investigative techniques, including molecular imaging and genetic analyses, will deepen our understanding of ejaculatory and orgasmic function. In this chapter, we discuss the neuroanatomical and biochemical pathways related to ejaculatory and orgasmic function and the promising future of investigation evaluating these conditions.

Keywords

Male sexual dysfunction Animal models Neuropeptides Molecular imaging Genetic analysis 

References

  1. 1.
    Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281:537–44.CrossRefPubMedGoogle Scholar
  2. 2.
    Catalan J, Klimes I, Day A, et al. The psychosocial impact of HIV infection in gay men. A controlled investigation and factors associated with psychiatric morbidity. Br J Psychiatry. 1992;161:774–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Catalan J, Klimes I, Bond A, et al. The psychosocial impact of HIV infection in men with haemophilia: controlled investigation and factors associated with psychiatric morbidity. J Psychosom Res. 1992;36:409–16.CrossRefPubMedGoogle Scholar
  4. 4.
    Chan JS, Olivier B, de Jong TR, et al. Translational research into sexual disorders: pharmacology and genomics. Eur J Pharmacol. 2008;585:426–35.CrossRefPubMedGoogle Scholar
  5. 5.
    Kruger TH, Hartmann U, Schedlowski M. Prolactinergic and dopaminergic mechanisms underlying sexual arousal and orgasm in humans. World J Urol. 2005;23:130–8.CrossRefPubMedGoogle Scholar
  6. 6.
    de Jong TR, Veening JG, Olivier B, et al. Oxytocin involvement in SSRI-induced delayed ejaculation: a review of animal studies. J Sex Med. 2007;4:14–28.CrossRefPubMedGoogle Scholar
  7. 7.
    de Jong TR, Veening JG, Waldinger MD, et al. Serotonin and the neurobiology of the ejaculatory threshold. Neurosci Biobehav Rev. 2006;30:893–907.CrossRefPubMedGoogle Scholar
  8. 8.
    Bitran D, Hull EM. Pharmacological analysis of male rat sexual behavior. Neurosci Biobehav Rev. 1987;11:365–89.CrossRefPubMedGoogle Scholar
  9. 9.
    Hull EM, Muschamp JW, Sato S. Dopamine and serotonin: influences on male sexual behavior. Physiol Behav. 2004;83:291–307.CrossRefPubMedGoogle Scholar
  10. 10.
    Agmo A. Male rat sexual behavior. Brain Res Brain Res Protoc. 1997;1:203–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Rees PM, Fowler CJ, Maas CP. Sexual function in men and women with neurological disorders. Lancet. 2007;369:512–25.CrossRefPubMedGoogle Scholar
  12. 12.
    Burns JM, Swerdlow RH. Right orbitofrontal tumor with pedophilia symptom and constructional apraxia sign. Arch Neurol. 2003;60:437–40.CrossRefPubMedGoogle Scholar
  13. 13.
    Devinsky J, Sacks O, Devinsky O. Kluver-Bucy syndrome, hypersexuality, and the law. Neurocase. 2010;16:140–5.CrossRefPubMedGoogle Scholar
  14. 14.
    Dieckmann G, Schneider-Jonietz B, Schneider H. Psychiatric and neuropsychological findings after stereotactic hypothalamotomy, in cases of extreme sexual aggressivity. Acta Neurochir Suppl. 1988;44:163–6.PubMedGoogle Scholar
  15. 15.
    Freeman W. Sexual behavior and fertility after frontal lobotomy. Biol Psychiatry. 1973;6:97–104.PubMedGoogle Scholar
  16. 16.
    Stoleru S, Fonteille V, Cornelis C, et al. Functional neuroimaging studies of sexual arousal and orgasm in healthy men and women: a review and meta-analysis. Neurosci Biobehav Rev. 2012;36:1481–509.CrossRefPubMedGoogle Scholar
  17. 17.
    Georgiadis JR, Reinders AA, Van der Graaf FH, et al. Brain activation during human male ejaculation revisited. Neuroreport. 2007;18:553–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Holstege G, Georgiadis JR, Paans AM, et al. Brain activation during human male ejaculation. J Neurosci Off J Soc Neurosci. 2003;23:9185–93.Google Scholar
  19. 19.
    Luo S, Lu Y, Wang F, et al. Association between polymorphisms in the serotonin 2C receptor gene and premature ejaculation in Han Chinese subjects. Urol Int. 2010;85:204–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Zhang XR, Zhang ZJ, Zhu RX, et al. Sexual dysfunction in male schizophrenia: influence of antipsychotic drugs, prolactin and polymorphisms of the dopamine D2 receptor genes. Pharmacogenomics. 2011;12:1127–36.CrossRefPubMedGoogle Scholar
  21. 21.
    Perlis RH, Laje G, Smoller JW, et al. Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients. Neuropsychopharmacology. 2009;34:1819–28.CrossRefPubMedGoogle Scholar
  22. 22.
    Courtois F, Carrier S, Charvier K, et al. The control of male sexual responses. Curr Pharm Des. 2013;19:4341–56.CrossRefPubMedGoogle Scholar
  23. 23.
    Wolters JP, Hellstrom WJ. Current concepts in ejaculatory dysfunction. Rev Urol. 2006;8 Suppl 4:S18–25.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Giuliano F, Clement P. Serotonin and premature ejaculation: from physiology to patient management. Euro Urol. 2006;50:454–66.CrossRefGoogle Scholar
  25. 25.
    McMahon CG, Jannini E, Waldinger M, et al. Standard operating procedures in the disorders of orgasm and ejaculation. J Sex Med. 2013;10:204–29.CrossRefPubMedGoogle Scholar
  26. 26.
    Perelman M, McMahon C, Barada J. Evaluation and treatment of the ejaculatory disorders. In: Lue T, editor. Atlas of male sexual dysfunction. Philadelphia: Current Medicine, Inc; 2004. p. 127–57.CrossRefGoogle Scholar
  27. 27.
    Meisel RL, Sachs BD. The physiology of male sexual behavior. In: Knobil E, Neill JD, editors. The physiology of reproduction. New York: Raven; 2005. p. 3–105.Google Scholar
  28. 28.
    Damasio H, Grabowski T, Frank R, et al. The return of Phineas Gage: clues about the brain from the skull of a famous patient. Science. 1994;264:1102–5.CrossRefPubMedGoogle Scholar
  29. 29.
    Aloni R, Katz S. A review of the effect of traumatic brain injury on the human sexual response. Brain Inj. 1999;13:269–80.CrossRefPubMedGoogle Scholar
  30. 30.
    Montorsi F, Perani D, Anchisi D, et al. Brain activation patterns during video sexual stimulation following the administration of apomorphine: results of a placebo-controlled study. Eur Urol. 2003;43:405–11.CrossRefPubMedGoogle Scholar
  31. 31.
    Mallick HN, Tandon S, Jagannathan NR, et al. Brain areas activated after ejaculation in healthy young human subjects. Indian J Physiol Pharmacol. 2007;51:81–5.PubMedGoogle Scholar
  32. 32.
    Tiihonen J, Kuikka J, Kupila J, et al. Increase in cerebral blood flow of right prefrontal cortex in man during orgasm. Neurosci Lett. 1994;170:241–3.CrossRefPubMedGoogle Scholar
  33. 33.
    Bishop JR, Moline J, Ellingrod VL, et al. Serotonin 2A–1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects. Neuropsychopharmacology. 2006;31:2281–8.PubMedGoogle Scholar
  34. 34.
    Clayton AH, McGarvey EL, Clavet GJ. The changes in sexual functioning questionnaire (CSFQ): development, reliability, and validity. Psychopharmacol Bull. 1997;33:731–45.PubMedGoogle Scholar
  35. 35.
    Arranz MJ, Munro J, Owen MJ, et al. Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine. Mol Psychiatry. 1998;3:61–6.CrossRefPubMedGoogle Scholar
  36. 36.
    McGahuey CA, Gelenberg AJ, Laukes CA, et al. The Arizona sexual experience scale (ASEX): reliability and validity. J Sex Marital Ther. 2000;26:25–40.CrossRefPubMedGoogle Scholar
  37. 37.
    Rosen RC, Cappelleri JC, Smith MD, et al. Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11:319–26.CrossRefPubMedGoogle Scholar
  38. 38.
    Rush AJ, Trivedi M, Fava M. Depression, IV: STAR*D treatment trial for depression. Am J Psychiatry. 2003;160:237.CrossRefPubMedGoogle Scholar
  39. 39.
    Kurose K, Hiratsuka K, Ishiwata K, et al. Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depression. Psychiatry Res. 2012;198:424–9.CrossRefPubMedGoogle Scholar
  40. 40.
    Jern P, Westberg L, Ankarberg-Lindgren C, et al. Associations between salivary testosterone levels, androgen-related genetic polymorphisms, and self-estimated ejaculation latency time. Sex Med. 2014;2:107–14.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Zuccarello D, Ghezzi M, Pengo M, et al. No difference in 5-HTTLPR and Stin2 polymorphisms frequency between premature ejaculation patients and controls. J Sex Med. 2012;9:1659–68.CrossRefPubMedGoogle Scholar
  42. 42.
    Perelman M, McMahon C, Barada J. Evaluation and treatment of ejaculatory disorders. In: Lue TF, editor. Atlas of male sexual dysfunction. Philadelphia: Current Medicine LLC; 2004. p. 127–57.CrossRefGoogle Scholar
  43. 43.
    Waldinger MD. The neurobiological approach to premature ejaculation. J Urol. 2002;168:2359–67.CrossRefPubMedGoogle Scholar
  44. 44.
    McMahon CG, Althof SE, Waldinger MD, et al. An evidence-based definition of lifelong premature ejaculation: report of the international society for sexual medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med. 2008;5:1590–606.CrossRefPubMedGoogle Scholar
  45. 45.
    Laumann EO, Nicolosi A, Glasser DB, et al. Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the global study of sexual attitudes and behaviors. Int J Impot Res. 2005;17:39–57.CrossRefPubMedGoogle Scholar
  46. 46.
    Basile Fasolo C, Mirone V, Gentile V, et al. Premature ejaculation: prevalence and associated conditions in a sample of 12,558 men attending the andrology prevention week 2001 – a study of the Italian society of andrology (SIA). J Sex Med. 2005;2:376–82.CrossRefPubMedGoogle Scholar
  47. 47.
    Porst H, Montorsi F, Rosen RC, et al. The premature ejaculation prevalence and attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol. 2007;51:816–23. discussion 824.CrossRefPubMedGoogle Scholar
  48. 48.
    Nicolosi A, Laumann EO, Glasser DB, et al. Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors. Urology. 2004;64:991–7.CrossRefPubMedGoogle Scholar
  49. 49.
    Corona G, Rastrelli G, Maseroli E, et al. Sexual function of the ageing male. Best Pract Res Clin Endocrinol Metab. 2013;27:581–601.CrossRefPubMedGoogle Scholar
  50. 50.
    Witt MA, Grantmyre JE. Ejaculatory failure. World J Urol. 1993;11:89–95.CrossRefPubMedGoogle Scholar
  51. 51.
    Master VA, Turek PJ. Ejaculatory physiology and dysfunction. Urol Clin N Am. 2001;28:363–75. x.CrossRefGoogle Scholar
  52. 52.
    Vale J. Ejaculatory dysfunction. BJU Int. 1999;83:557–63.CrossRefPubMedGoogle Scholar
  53. 53.
    Perelman MA, Rowland DL. Retarded ejaculation. World J Urol. 2006;24:645–52.CrossRefPubMedGoogle Scholar
  54. 54.
    Johansson A, Jern P, Santtila P, et al. The genetics of sexuality and aggression (GSA) twin samples in Finland. Twin Res Hum Genet. 2013;16:150–6.CrossRefPubMedGoogle Scholar
  55. 55.
    Rowland DL. Penile sensitivity in men: a composite of recent findings. Urology. 1998;52:1101–5.CrossRefPubMedGoogle Scholar
  56. 56.
    Paick JS, Jeong H, Park MS. Penile sensitivity in men with premature ejaculation. Int J Impot Res. 1998;10:247–50.CrossRefPubMedGoogle Scholar
  57. 57.
    Motofei IG, Rowland DL. Neurophysiology of the ejaculatory process: developing perspectives. BJU Int. 2005;96:1333–8.CrossRefPubMedGoogle Scholar
  58. 58.
    Roberts M, Jarvi K. Steps in the investigation and management of low semen volume in the infertile man. Can Urol Assoc J. 2009;3:479–85.PubMedPubMedCentralGoogle Scholar
  59. 59.
    Lundin KB, Giwercman YL, Rylander L, et al. Androgen receptor gene GGN repeat length and reproductive characteristics in young Swedish men. Eur J Endocrinol. 2006;155:347–54.CrossRefPubMedGoogle Scholar
  60. 60.
    Erenpreiss J, Tsarev I, Giwercman A, et al. The impact of androgen receptor polymorphism and parental ethnicity on semen quality in young men from Latvia. Int J Androl. 2008;31:477–82.CrossRefPubMedGoogle Scholar
  61. 61.
    Ahlenius S, Larsson K, Svensson L, et al. Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacol Biochem Behav. 1981;15:785–92.CrossRefPubMedGoogle Scholar
  62. 62.
    Schachter M, Parkes JD. Fluvoxamine and clomipramine in the treatment of cataplexy. J Neurol Neurosurg Psychiatry. 1980;43:171–4.CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Ahlenius S, Larsson K. Synergistic actions of the 5-HT1A receptor antagonist WAY-100635 and citalopram on male rat ejaculatory behavior. Eur J Pharmacol. 1999;379:1–6.CrossRefPubMedGoogle Scholar
  64. 64.
    Ahlenius S, Larsson K. Evidence for an involvement of 5-HT1B receptors in the inhibition of male rat ejaculatory behavior produced by 5-HTP. Psychopharmacology. 1998;137:374–82.CrossRefPubMedGoogle Scholar
  65. 65.
    de Jong TR, Pattij T, Veening JG, et al. Citalopram combined with WAY 100635 inhibits ejaculation and ejaculation-related Fos immunoreactivity. Eur J Pharmacol. 2005;509:49–59.CrossRefPubMedGoogle Scholar
  66. 66.
    Hillegaart V, Ahlenius S. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181. Br J Pharmacol. 1998;125:1733–43.CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Li Q, Muma NA, van de Kar LD. Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist. J Pharmacol Exp Ther. 1996;279:1035–42.PubMedGoogle Scholar
  68. 68.
    Li Q, Muma NA, Battaglia G, et al. A desensitization of hypothalamic 5-HT1A receptors by repeated injections of paroxetine: reduction in the levels of G(i) and G(o) proteins and neuroendocrine responses, but not in the density of 5-HT1A receptors. J Pharmacol Exp Ther. 1997;282:1581–90.PubMedGoogle Scholar
  69. 69.
    Jern P, Westberg L, Johansson A, et al. Are single nucleotide polymorphisms in the oxytocin and vasopressin 1A/1B receptor genes likely candidates for variation in ejaculatory function? BJU Int. 2012;110:E1173–80.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Center for Reproductive Medicine, Scott Department of UrologyBaylor College of MedicineHoustonUSA
  2. 2.Department of UrologyStanford University School of MedicinePalo AltoUSA

Personalised recommendations